JPS5675428A - Hypoglycemic agent containing procainamide hydrochloride - Google Patents

Hypoglycemic agent containing procainamide hydrochloride

Info

Publication number
JPS5675428A
JPS5675428A JP15162979A JP15162979A JPS5675428A JP S5675428 A JPS5675428 A JP S5675428A JP 15162979 A JP15162979 A JP 15162979A JP 15162979 A JP15162979 A JP 15162979A JP S5675428 A JPS5675428 A JP S5675428A
Authority
JP
Japan
Prior art keywords
procainamide hydrochloride
agent containing
hypoglycemic
formula
active constituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15162979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5741443B2 (enExample
Inventor
Ayanori Takabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP15162979A priority Critical patent/JPS5675428A/ja
Publication of JPS5675428A publication Critical patent/JPS5675428A/ja
Publication of JPS5741443B2 publication Critical patent/JPS5741443B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP15162979A 1979-11-21 1979-11-21 Hypoglycemic agent containing procainamide hydrochloride Granted JPS5675428A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15162979A JPS5675428A (en) 1979-11-21 1979-11-21 Hypoglycemic agent containing procainamide hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15162979A JPS5675428A (en) 1979-11-21 1979-11-21 Hypoglycemic agent containing procainamide hydrochloride

Publications (2)

Publication Number Publication Date
JPS5675428A true JPS5675428A (en) 1981-06-22
JPS5741443B2 JPS5741443B2 (enExample) 1982-09-03

Family

ID=15522710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15162979A Granted JPS5675428A (en) 1979-11-21 1979-11-21 Hypoglycemic agent containing procainamide hydrochloride

Country Status (1)

Country Link
JP (1) JPS5675428A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013043925A1 (en) * 2011-09-21 2013-03-28 Gilead Sciences, Inc. Sodium channel blockers reduce glucagon secretion
US9403782B2 (en) 2011-05-10 2016-08-02 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US9676760B2 (en) 2011-07-01 2017-06-13 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2018037103A1 (en) * 2016-08-26 2018-03-01 Idogen Ab Procainamide for treating immune disorders and for modulating ido expression

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9403782B2 (en) 2011-05-10 2016-08-02 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US9682998B2 (en) 2011-05-10 2017-06-20 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US9676760B2 (en) 2011-07-01 2017-06-13 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2013043925A1 (en) * 2011-09-21 2013-03-28 Gilead Sciences, Inc. Sodium channel blockers reduce glucagon secretion
WO2018037103A1 (en) * 2016-08-26 2018-03-01 Idogen Ab Procainamide for treating immune disorders and for modulating ido expression

Also Published As

Publication number Publication date
JPS5741443B2 (enExample) 1982-09-03

Similar Documents

Publication Publication Date Title
ES8406992A1 (es) Un derivado de un alcohol b,v-dihidropoliprenilico.
JPS5551020A (en) Remedy for rheumatism
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57109721A (en) Carcinostatic agent
JPS57140716A (en) Antiallergic agent
JPS5630917A (en) Preventive and remedy for hepatitis
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5675432A (en) Antitumor agent containing ethyl piperidylacetylaminobenzoate
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
JPS5731616A (en) Relaxing agent for muscle comprising benzofurancarboxylic acid amide
JPS5675430A (en) Antiarteriosclerotic agent containing ethyl piperidylacetylaminobenzoate
JPS5675431A (en) Hypoglycemic agent containing ethyl piperidylacetylaminobenzoate
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5668611A (en) Novel antiallergic agent
JPS5536454A (en) Novel immunosuppressive agent
JPS5675429A (en) Anti-inflammatory agent containing ethyl piperidylacetylaminobenzoate
JPS5742620A (en) Novel antiulcer agent
JPS57128625A (en) Carcinostatic
JPS5675426A (en) Anti-inflammatory agent containing procainamide hydrochloride
JPS568317A (en) Preventive and remedy for complicating disease of diabetes mellitus
JPS5639018A (en) Remedy for cancer
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5569510A (en) Carcinostatic agent
JPS5498339A (en) Carcinostatic agent